Navigation Links
WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry
Date:1/2/2013

Cypress, CA, Costa Mesa, CA, Langhorne, PA, Garden City, NY (PRWEB) January 02, 2013

WCCT Global, a Full Service Contract Research Organization (CRO) supporting Phase I - IV biopharmaceutical and device development has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the US to help them enhance the capabilities of the VCT Clinical Trials Database Registry system. This new enhancement designed in collaboration with WCCT enables the Investigator to document study-participant adherence to medication schedules. Mel Affrime, Sr. VP R&D, WCCT said, “Patient adherence to clinical research protocol procedures, is critical along with returning to the investigational site for study procedures and safety assessments. This added enhancement now offered by VCT adds another level of security in the validity of the data that we capture for our clients”.

Mitchell Efros, MD, FACS, CEO and President of Verified Clinical Trials, stated "The recently released study medication adherence reminder system will improve dosing compliance in clinical trials. The module has the ability to remind the research volunteer to take the medication directly through the VCT registry. There is also the option of having the research subject respond to the reminder signaling their compliance and execution of the required dosing. WCCT Global, one of the early subscribers to our database, has always been an industry leader in their efforts to ensure the safety of their study participants and the quality of their clinical data. It has been a pleasure working with the WCCT team to make this enhancement available to our entire network of subscribers.”

About WCCT Global

WCCT Global is a multi-site, Full Service global Contract Research Organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive to for tomorrow’s therapies to be available today,” truly exemplifies the focus and reason for their cutting edge work. As a drug development partner, WCCT Global partners with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support with an emphasis on overseeing and executing on trials in special disease populations, ethnobridging volunteers, and cardiac safety . In addition, they extensive experience with healthy volunteer studies including First-in-Human (FIH) as well as specific therapeutic expertise in Allergy, Asthma, Infectious Disease, Pediatric, Ophthalmology, Oncology, Renal, Serial ECGs, and Vaccines. Visit WCCT Global on the web at http://www.wcctglobal.com.

Contact for WCCT Global

Talia Nikolao
Vice President, Business Development
PR(at)wcct(dot)com
714-668-1500

About Verified Clinical Trials:

Verified Clinical Trials was developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of clinical trial database registries. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities.

To RSVP or for more information, visit http://www.verifiedclinicaltrials.com.

Verified Clinical Trials Contact Info
Kerri Weingard, ANP, Chief Operating Officer
Verified Clinical Trials +1 516 998-7499

Read the full story at http://www.prweb.com/releases/trialdosingreminder/VerifiedClinicalTrials/prweb10269825.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... and LONDON , February 9, 2016 /PRNewswire/ ... tech replace paper and protect IP   ... laboratory notebook (ELN) will be rolled out in ... and development (R&D) and protect valuable IP. Users will be ... a specific researcher or experiment as part of the application, ...
(Date:2/9/2016)... Feb. 9, 2016 ... 2016", report provides in depth insights on ... around the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. ... in various stages of development including Discovery, ... III and Preregistration. Report covers the product ...
(Date:2/8/2016)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced that it has entered into a ... Growth Capital, Inc. and Hercules Technology III, L.P. ... --> --> CytRx ... under the loan and security agreement.  The proceeds ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... Board of Directors. Todorow is the Executive Vice President for Corporate Services and ... Todorow oversees Finance, Accounts Payable, Payroll, Billing Operations, Treasury, Managed Care Contracting, Supply ...
Breaking Biology Technology:
(Date:2/3/2016)... Feb. 3, 2016 Vigilant Solutions announces today ... in Missouri solved two recent ... (LPR) data from Vigilant Solutions. Brian Wenberg ... which the victim was walking out of a convenience store and witnessed an ... to his vehicle, striking his vehicle and leaving the ...
(Date:2/2/2016)... , Feb. 2, 2016 Checkpoint ... that Rising Market Are you interested in ... forecasts revenues for checkpoint inhibitors. Visiongain,s report gives ... submarket, product and national level. Avoid falling ... what progress, opportunities and revenues those emerging cancer ...
(Date:2/1/2016)... February 1, 2016 Rising sales ... drive global touchfree intuitive gesture control market ... Rising sales of consumer electronics coupled with new technological ... size through 2020   ... with new technological advancements to drive global touchfree intuitive ...
Breaking Biology News(10 mins):